(Waldner 2006) A double-blind RCT (n=30) in patients receiving high-dose interleukin-2 therapy reported a reduction in serious cardiac events (e.g., arrhythmias and acute heart failure) with L-carnitine use compared to no therapy, but the small sample size and heterogeneity of the cancer types limit generalizability
See: Nutritional Medicine Update: The Clinical Applications of L-Carnitine
IDEAL FOR SPORTS: Our sports supplement adapts to your lifestyle
Although the higher dose of acetyl-l-carnitine did not improve survival (adjusted odds ratio [aOR] 1.18, 95% CI 0.463.02), the lower dose did (aOR 0.27, 95% CI 0.100.71)
- 100% free of essential oils, silicones, fragrance/dyes, and solvent alcohols
Th1 chemokines in autoimmune endocrine disorders